Charles Schwab Investment Management Inc. Takes Position in Grail, Inc. (NASDAQ:GRAL)

Charles Schwab Investment Management Inc. acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, Holdings Channel.com reports. The firm acquired 22,954 shares of the company’s stock, valued at approximately $410,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of Grail in the fourth quarter valued at about $244,000. Moloney Securities Asset Management LLC purchased a new stake in Grail during the 4th quarter valued at about $559,000. Rhumbline Advisers acquired a new stake in Grail in the 4th quarter valued at about $456,000. Wesbanco Bank Inc. purchased a new position in Grail in the 4th quarter worth approximately $523,000. Finally, Slow Capital Inc. acquired a new position in shares of Grail during the 4th quarter worth approximately $2,379,000.

Insider Transactions at Grail

In related news, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares of the company’s stock, valued at approximately $17,461,797.60. This trade represents a 0.38 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 7,625 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,550 shares of company stock worth $360,436.

Wall Street Analyst Weigh In

Separately, Morgan Stanley increased their price target on Grail from $16.00 to $20.00 and gave the company an “equal weight” rating in a report on Tuesday, March 18th.

Grail Price Performance

Shares of GRAL stock opened at $25.54 on Tuesday. The company’s 50-day moving average price is $34.19 and its 200-day moving average price is $22.56. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

Grail (NASDAQ:GRAL) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analysts’ expectations of $35.33 million. Equities research analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.